Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
F-star Therapeutics, Inc. (SBPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/20/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
03/17/2023 SC 13G Beryl Capital Management LLC reports a 0% stake in F-Star Therapeutics, Inc.
03/14/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/14/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/14/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/14/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/14/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/09/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/09/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/09/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/09/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/09/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/09/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
03/09/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/09/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/09/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/09/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/09/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/09/2023 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of F-star Therapeutics, Inc",
"Amended and Restated Bylaws of F-star Therapeutics, Inc"
03/09/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/09/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
03/09/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/07/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/07/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
03/07/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma"
03/06/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
03/06/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
03/06/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
02/23/2023 8-K Entry into a Material Definitive Agreement, Other Events  Interactive Data
02/23/2023 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
02/23/2023 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
02/14/2023 SC 13G/A Ridgeback Capital Investments L.P. reports a 0.2% stake in F-star Therapeutics, Inc.
02/14/2023 SC 13G/A Ridgeback Capital Investments L.P. reports a 0.2% stake in F-star Therapeutics, Inc.
02/09/2023 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy